Clinical trials for variceal bleeding: And the winner is - The patient

Liver Transplantation

Volumn 13, Issue 9, 2007, Pages 1212-1213

  Boyer, Thomas D ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENBUCRILATE; PROPRANOLOL;

CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EDITORIAL; ESOPHAGUS VARICES BLEEDING; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STOMACH HEMORRHAGE; STOMACH ULCER; STOMACH VARICES; STOMACH VARICES BLEEDING; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT; VEIN LIGATION;

ADRENERGIC BETA-ANTAGONISTS; CLINICAL TRIALS; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER TRANSPLANTATION; PROPRANOLOL; RECURRENCE; SURVIVAL ANALYSIS;

EID: 34648825204     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21122     Document Type: Editorial

References (17)

1. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003;98:653-659.
2. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004;40:652-659.
3. Stokkeland K, Brandt L, Ekbom A, Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969-2002. Hepatology 2006;43:500-505.
4. Khuroo MS, Khuroo NS, Farahat KL, Khuroo YS, Sofi AA, Dahab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005;21:347-361.
5. Sarin SK, Wadhawan M, Agarwal SR, Tyagi P, Sharma BC. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol 2005;100;797-804.
6. Cales P, Masliah C, Bernard B, Garnier P-P, Silvain C, Szostak-Talbodec M, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 2001;344:23-28.
7. Hou M-C, Lin H-C, Liu T-T, Kuo B, Lee F-Y, Chang F-Y, et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 2004;39:746-753.
8. Boyer TD, Haskel Z. AASLD Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005;41: 386-400.
9. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001;345:669-681.
10. Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LM, et al. Multi-center randomized trial of distal spleno-renal shunt [DSRS] vs. transjugular intrahepatic portal systemic shunt [TIPS] for control of refractory variceal bleeding in patients with Child's class A or B cirrhosis. Gastroenterolgy 2006;130:1643-1651.
11. Jutabha R, Jensen DM, Martin P, Savides T, Han S-H, Gornbein J. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high risk esophageal varices. Gastroenterology 2005;128.870-881.
12. Norberto L, Polese L, Cillo U, Grigoletto F, Burroughs A, Neri D, et al. A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transpl 2007: 1272-1278.
13. Tan P-C, Hou M-C, Lin H-C, Liu T-T, Lee FY, Chang J-Y, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-2cyanoacrylate injection versus band ligation. Hepatology 2006; 43:690-697.
14. Groszmann RJ, Garica-Tsao G, Bosch J, Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254-2261.
15. Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 2004;127:476-484.
16. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003;361:952-954.
17. Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, Gatta A. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000;32:930-934.